Cannabistiva (Cannabistiva) EBIT : $-1.60 Mil (TTM As of Sep. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Cannabistiva EBIT?

Cannabistiva's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2023 was $-0.14 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2023 was $-1.60 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Cannabistiva's annualized ROC % for the quarter that ended in Sep. 2023 was -37.92%. Cannabistiva's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -18,800.00%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Cannabistiva's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -107.89%.

Cannabistiva EBIT Historical Data

The historical data trend for Cannabistiva's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabistiva EBIT Chart

Cannabistiva Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EBIT

Get a 7-Day Free Trial

-4.87

-3.96

-1.65

-2.28

-1.14

Cannabistiva Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
EBIT	Get a 7-Day Free Trial															-0.08	-0.66	-0.49	-0.31	-0.14

Competitive Comparison of Cannabistiva's EBIT

For the Health Information Services subindustry, Cannabistiva's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannabistiva's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cannabistiva's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cannabistiva's EV-to-EBIT falls into.

Cannabistiva EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.60 Mil.

Cannabistiva (OTCPK:CBDS) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Cannabistiva's annualized ROC % for the quarter that ended in Sep. 2023 is calculated as:

	ROC % (Q: Sep. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Sep. 2023 ))	/ count )
=	-0.888 * ( 1 - 0% )	/	( (2.379	+	2.305)	/ 2 )
=	-0.888	/	2.342
=	-37.92 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	2.082	-	0.15	-	( 0.059	-	max(0, 0.531	-	0.084	+	0.059	))
=	2.379

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	2.123	-	0.086	-	( 0.145	-	max(0, 0.431	-	0.163	+	0.145	))
=	2.305

Note: The Operating Income data used here is four times the quarterly (Sep. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Cannabistiva's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Sep. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Sep. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-0.564	/	( ( (0.003 + max(-0.125, 0))	+	(0.003 + max(-0.067, 0)) )	/	2 )
=	-0.564	/	( ( 0.003	+	0.003 )	/	2 )
=	-0.564	/	0.003
=	-18,800.00 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0.025)	-	(0.15	+	0	+	0)
=	-0.125

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0.018)	-	(0.086	+	0	+	-0.00099999999999995)
=	-0.067

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Cannabistiva's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Sep. 2023 )
	=	-1.6	/	1.483
	=	-107.89 %

Cannabistiva EBIT Related Terms

Thank you for viewing the detailed overview of Cannabistiva's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannabistiva (Cannabistiva) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cannabis Sativa Inc (OTCPK:CBDS) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

450 Hillside Drive, Suite A224, Mesquite, NV, USA, 89027

Website

https://www.cannabissativainc.com

Cannabis Sativa Inc along with its subsidiaries engages in the telemedicine business. It offers an online telemedicine platform providing customers access to knowledgeable physicians to obtain a medical marijuana recommendation.

Executives

Brad E Herr	director, officer: Chief Financial Officer	5413 S SAYBROOK LANE, SPOKANE WA 99223
David Tobias	director, 10 percent owner	PO BOX 1602, MESQUITE NV 89024
Tankson Robert N. Iii	director	6057 RYAN RANCH AVE, LAS VEGAS NV 89130
Donald Lundbom	officer: CHIEF FINANCIAL OFFICER	37177 N WILD BARLEY PATH, SAN TAN VALLEY AZ 85140
Sadia P Barrameda	10 percent owner	PO BOX 1363, DISCOVERY BAY CA 94505
Mike Gravel	director	4467 OCEAN HEIGHTS CT,, SEASIDE CA 93955
Stephen Michael Downing	director	152 LA VERNE AVENUE, LONG BEACH CA 90803
Debby Goldsberry	director	1707 LEIMERT BLVD, OAKLAND CA 94607
Trevor S Reed	director	20 BRAZOS TRAIL COURT, PLACITAS NM 87043
Catherine J Carroll	director, officer: CFO and Treasurer	450 HILLSIDE DRIVE A224, MESQUITE NV 89027
James Polin Gray	director	2531 CRESTVIEW DRIVE, NEWPORT BEACH CA 92663
Gary Earl Johnson	director, officer: President, CEO & Secretary	P.O. BOX 1858, EL PRADO NM 87529
Steve Kubby	director, 10 percent owner, officer: Chairman of the Board	317 JUDITH'S FANCY, ST. CROIX VI 00823-5335
Barry Robert Tobias	director	7305 DAMSEL LANE, FAIRVIEW TN 37062
Kirk Blosch	10 percent owner	2081 SOUTH LAKELINE DR, SALT LAKE CITY UT 84109